Publication:
Prognostic Factors Affecting Survival in Breast Cancer Patients Age 40 or Younger

dc.authorscopusid57219778461
dc.authorscopusid7003782364
dc.authorscopusid35112602400
dc.authorscopusid57199997973
dc.authorscopusid6602743597
dc.contributor.authorAkgün, C.
dc.contributor.authorKuru, B.
dc.contributor.authorYürüker, S.
dc.contributor.authorKarabacak, U.
dc.contributor.authorÖzen, N.
dc.date.accessioned2025-12-11T00:30:14Z
dc.date.issued2022
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Akgün] Can, Department of General Surgery, İstinye Üniversitesi, Istanbul, Turkey; [Kuru] Bekir, Department of General Surgery, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Yürüker] Savaş Savaş, Department of General Surgery, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Karabacak] Ufuk, Department of General Surgery, Medical Park Samsun Hospital, Samsun, Samsun, Turkey; [Özen] Necati, Department of General Surgery, İstinye Üniversitesi, Istanbul, Turkeyen_US
dc.description.abstractThe aims of this study were to identify the factors affecting survival and disease-free survival (DFS) in invasive breast cancer patients who underwent surgery for breast cancer age 40 or younger. Medical records of 216 women with breast carcinoma at age 40 or younger who underwent surgery at our Institution between October 2005 and May 2017 were retrospectively reviewed. One hundred and eighty eight invasive breast cancer patients that were eligible were categorized according to their clinical and pathological features. Univariate analyses of survival and DFS were performed by the Kaplan-Meier method and the log-rank test. Independent prognostic and predictive factors affecting survival and DFS were assessed by Cox regression proportional hazard method. 10-year survival and DFS were 85 and 74%, respectively. Axillary involvement, pathologic tumor size, HER 2 + subtype and Triple Negative subtype were found to be the prognostic factors that independently affected survival and DFS. The prognosis is worse in patients with axillary involvement, tumors larger than 2 cm, and HER 2+ and Triple Negative subtypes. These adverse prognostic factors should be considered during treatment and follow-up of patients age 40 or younger. © 2022 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.39.4.2
dc.identifier.endpage933en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85142454724
dc.identifier.scopusqualityQ4
dc.identifier.startpage928en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.39.4.2
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36875
dc.identifier.volume39en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universityen_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBreast Canceren_US
dc.subjectBreast Neoplasmsen_US
dc.subjectDisease-Free Survivalen_US
dc.subjectPrognosisen_US
dc.subjectSurvivalen_US
dc.titlePrognostic Factors Affecting Survival in Breast Cancer Patients Age 40 or Youngeren_US
dc.typeArticleen_US
dspace.entity.typePublication

Files